Project Grant R21AI178136

Award Date 6/1/24
Completion Date 4/30/26
Dollars Obligated $932K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Farmington, CT 06032, USA
Similar Awards
This federal Project Grant award for $215,810 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research to identify host proteins degraded in neurons and the role of the viral proteins ICP0 and the PUL55 complex in this process and in reactivation of herpes simplex virus type 1 (HSV-1) from latent infection. The primary awardee, the University of Virginia, will collaborate with a sub-awardee, the University of...
This $658,273 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to investigate how Herpes Simplex Virus 1 (HSV-1) interacts with and regulates the NLRP1 inflammasome pathway in human skin cells. The key goals are to understand the mechanisms by which the HSV-1 ICP0 protein activates stress-activated protein kinases and inhibits NLRP1 inflammasome formation, as...
This federal Project Grant award of $471,159.00 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to elucidate the mechanisms by which alpha herpesviruses, such as herpes simplex virus-1 (HSV-1), invade the peripheral nervous system. The primary objectives are to investigate how the response of peripheral nerves to the cytokine interferon lambda affects the transport of viral particles...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $651,832 to The Children's Hospital of Philadelphia (CHOP) Research Institute to conduct research on how Herpes Simplex Virus (HSV) manipulates the host cell's DNA damage response and proteome to promote viral infection and replication. The key objectives are to: 1) Define the intersection of phosphorylation and...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $248,999 to the University of Virginia to investigate the role of mitochondrial-endoplasmic reticulum (ER) contact sites (MERCs) in regulating mitochondrial DNA (mtDNA) release and innate immune responses to viral infections. The key objectives are to examine whether MERCs stimulate mtDNA release during herpes simplex...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) provides funding of $381,486 from July 1, 2024 to May 31, 2026 to the University of Kansas Center for Research Inc. The project aims to identify the mechanisms by which the herpes simplex virus (HSV) protein ICP0 binds to itself to enhance viral transcription and replication, with the long-term goal of understanding viral factors...
This $384,363 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research at Temple University to investigate the role of the Pellino1 (PELI1) protein in regulating antiviral immunity in the skin. The research aims to provide improved understanding of how PELI1 functions in keratinocytes and the epidermis to limit the severity and spread of herpes simplex virus (HSV)...
The federal Project Grant award of $363,969.00, funded by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to characterize the mechanism of Herpes Simplex Virus-1 (HSV-1) latency and reactivation regulated by thyroid hormone. The research aims to: 1) Use computer-guided mutagenesis to generate chimeric HSV-1 viruses and determine the impact of...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under CFDA Program 93.855 Allergy and Infectious Diseases Research, aims to characterize the structure of key glycoprotein complexes involved in herpes simplex virus (HSV) cell entry. The $236,292 award to Tufts University School of Medicine will enable the use of cryo-electron microscopy (cryoEM) to obtain high-resolution structural "snapshots" of the GD/GH/GL and GH/GL/GB glycoprotein...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $104,984 to Pennsylvania State University to conduct research on how the Merkel Cell Polyomavirus (MCPyV) induces the nucleolar stress response (NSR) in infected cells. The goal is to determine the mechanisms by which MCPyV's large tumor antigen (LT) inhibits ribosomal biogenesis, leading to activation of the...

MOLECULAR MECHANISMS OF SENSING NUCLEAR STRESS AND LAUNCHING ANTIVIRAL DEFENSE BY PML - ABSTRACT THE HUMAN HERPESVIRUSES ARE RESPONSIBLE FOR LIFELONG DEBILITATING AND CONGENITAL INFECTIONS, AND SOME MEMBERS OF THIS FAMILY ARE ASSOCIATED WITH HUMAN CANCERS. HSV CAUSES SIGNIFICANT DISEASE DURING ACUTE INFECTION AND ESTABLISHES PERSISTENT LATENT INFECTIONS IN SENSORY NEURONS FOR THE LIFE OF THE HOST LEADING TO REACTIVATION AND RECURRENT DISEASE. THIS PROPOSAL IS BASED ON A SERIES OF OBSERVATIONS ABOUT THE INTERPLAY BETWEEN HSV INFECTION AND THE INTRINSICALLY ANTIVIRAL CELLULAR PROTEIN, PML. IN RESPONSE TO INTERFERON TREATMENT, OXIDATIVE STRESS, DNA DAMAGE, AND VIRAL INFECTION PML OLIGOMERIZES TO FORM A MESH-LIKE SPHERICAL SHELL AROUND HETEROGENEOUS, PHASE- SEPARATED NUCLEAR CONDENSATES, CALLED PML NUCLEAR BODIES (PML-NBS). PML OLIGOMERIZATION LEADS TO THE ACTIVATION OF ITS SUMO LIGASE ACTIVITY, WHICH IN TURN INDUCES THE RECRUITMENT OF DOZENS OF CELLULAR PROTEINS THAT CONTAIN SUMO-INTERACTING MOTIFS (SIMS) INCLUDING REPRESSORS OF GENE EXPRESSION INTO PML-NBS VIA SUMO/SIM INTERACTIONS. PML-NBS ARE ANTI-VIRAL, HOWEVER, THE EXACT MECHANISM OF THEIR ACTION REMAINS POORLY UNDERSTOOD. PML-NBS SIZE AND NUMBER INCREASE IN RESPONSE TO HSV INFECTION, AND THEY ARE ACTIVELY TARGETED FOR DEGRADATION BY HSV1 AS A MECHANISM TO COUNTERACT THEIR ANTIVIRAL EFFECTS. DURING HSV INFECTION PML-NBS HAVE OFTEN BEEN OBSERVED ADJACENT TO THE SITES OF VIRAL DNA REPLICATION AND HAVE RECENTLY BEEN SHOWN TO ENTRAP THE ENTIRE VIRAL GENOME. DESPITE A RUDIMENTARY UNDERSTANDING OF THESE PROCESSES, MANY QUESTIONS REMAIN ABOUT HOW PML-NB FORMATION IS TRIGGERED BY HSV INFECTION AND HOW THEY ARE RECRUITED TO VIRAL GENOMES. OLIGOMERIZATION AND SUMOYLATION OF PML HAVE BEEN SHOWN TO BE ESSENTIAL FOR THE EFFECTIVE FORMATION OF PML-NBS IN RESPONSE TO STRESS. IN AIM 1 WE WILL IDENTIFY PML DOMAINS THAT ARE NECESSARY FOR ITS SUMO-E3 LIGASE ACTIVITY AND REQUIRED FOR FORMATION OF THE PML-NBS. ONE OF THE MOST SURPRISING ASPECTS OF PML-NB FORMATION IS THEIR ABILITY TO FORM AROUND AND ENTRAP VIRAL DNA, RESULTING IN GENOME SILENCING. THE PROPERTIES OF PML THAT PROMOTE THIS UNUSUAL ABILITY TO RECOGNIZE VIRAL DNA ARE NOT UNDERSTOOD. IN AIM 2 WE WILL TEST THE HYPOTHESIS THAT PML CONTAINS A DNA-BINDING DOMAIN NECESSARY FOR RECRUITMENT OF PML-NBS TO VIRAL GENOMES. TOGETHER, THESE AIMS WILL PROBE THE FUNDAMENTAL MECHANISMS BEHIND THE TWO KEY EVENTS THAT TRIGGER THE FORMATION OF PML-NBS IN RESPONSE TO HSV INFECTION.

Posted 5/29/24, 12:00 AM